Faculty

Professor Juntra Karbwang Laothavorn

Speciality / Research theme / Keywords
Clinical Product
Programme director
Masters Programme

Qualifications

MD, DTM&H, PhD

Research gate or Linked-in account links

https://www.researchgate.net/profile/Juntra_Karbwang

Affiliation(s)

  • Thammasat University, Bangkok, Thailand
  • FERCAP, Bangkok, Thailand

Background

  • Juntra Karbwang Laothavorn MD, DTM&H, PhD has been a part of the Institution of Tropical Medicine, Nagasaki University, as Professor and Head of Clinical Product Development Department since April, 2012.  Her responsibility is to develop a mechanism and system for NEKKEN Clinical Health Product (drug/vaccine) development.
  • Prior to joining NEKKEN, she spent 14 years (1998-2012) at the World Health Organization’s Special Program on Tropical Disease Research (WHO/TDR) in Geneva, Switzerland.  She has produced a series of Standard Operating Procedures for WHO/TDR clinical investigators and clinical monitors, and coordinated the production of WHO Operational Guidelines for Ethics Committees That Review Biomedical Research (translated into more than 20 languages).
  • She spent 17 years (1981-1998) at the Tropical Research Institute, Mahidol University in Bangkok, Thailand.  Her last appointment was Professor of Clinical Tropical Medicine and Head of Clinical Tropical Pharmacology Unit.  Her academic research was concentrated on the Clinical Pharmacology of antimalarials.  She has published more than 140 original articles widely on clinical development of drugs for Tropical Diseases.

Teaching

  • Co-director of Conducting Responsible Research for TMGH
  • Course director for Clinical Tropical Pharmacology at the Institution of Tropical Medicine, Mahidol University, Bangkok, Thailand  (1981-1998)
  • Developed training curricula for clinical monitors, clinical investigators and members of ethics committee in African and Asian countries (1998-2012).
  • Developed curriculum for short training course in Product Research and Development in 2005 and teach annually on one module in good clinical practice at NEKKEN.

Research

  • Development of innovative method for enhanced informed consent form in clinical research (supported by WHO/TDR)
  • Assessment of the quality of Ethical Review for Clinical Research in Asia (Supported by WHO/TDR and FERCAP – www. FERCAP-SIDCER.org)
  • Development of Shiunko ointment for Cutaneous Leishmaniasis
  • Development of Khod Kamoa (herbal medicine) for Cholangiocarcinoma (in collaboration with Thammasat university and the Thai Government Pharmaceutical Organization)

The country/countries where you work currently

  • China
  • Korea
  • Taiwan
  • Bhutan
  • India
  • Indonesia
  • Philippines
  • Thailand
  • Malaysia
  • Sri Lanka
  • Ethiopia

Five MOST IMPORTANT/INTERESTING recent publications

  1. Nut Koonrungsesomboon, Supanimit Teekachunhatean, Nutthiya Hanprasertpong, Junjira Laothavorn, Kesara Na-Bangchang & Juntra Karbwang (2016).  Improved participants’ understanding in a healthy volunteer study using the SIDCER informed consent form:a randomized-controlled study.  Dur J Clin Pharmacol 72:413-421
  2. Kesara Na-Bangchang,  Oumer Ahmed,  Jemal Hussein, Kenji Hirayama, Panida Kongjam,  Abraham Aseffa,  and Juntra Karbwang (2016).  Exploratory, Phase II Controlled Trial of Shiunko Ointment Local Application Twice a Day for 4 Weeks in Ethiopian Patients with Localized Cutaneous Leishmaniasis  Evidence-Based Complementary and Alternative Medicine http://dx.doi.org/10.1155/2016/5984709
  3. Nut Koonrungsesomboon, Kesara Na-Bangchang, Juntra Karbwang. (2014) Therapeutic potential and pharmacological activities of Atractylodes lancea (Thunb.) DC. Asian Pacific Journal of Tropical Medicine, 412-420 Doi:10.1016/s1995-7645(14)60069-9
  4. Tullayakorn Plengsuriyakarn, Veerachai Thitapakorn, Kesara Na-Bangchang, Juntra Karbwang (2013). Thai Medicinal plants: Potential sources of anticholangiocarcinoma drugs. International Journal of Pharmacy and Pharmacology. 2(5), 068-082
  5. Juntra Karbwang and Kesara NaBangchang (2013) Practical Application of International Standards and Guidelines to Address Ethical Challenges in Clinical Trials. J Clinical Res Bioeth 4: 144. doi:10.4172/2155-9627.1000144

Message

Conducting responsible research is more than the desire to do the right thing. It is crucial that students recognize and appreciate the wide range of good practices in conducting research and publication. It is important that the students act responsibly to these standards throughout research processes. This training course addresses the topics of responsible research, good research practice, standards for development of protocol, data management and publication of research results. The training will elaborate required acceptable practices for achieving excellence in research across all fields and disciplines. The lectures will be complemented by examples and exercises, so that students have opportunities to apply the principles into practices.

PAGE TOP